Preclinical Repair

TB-500

Synthetic fragment related to thymosin β4

Fragment associated with cell migration and angiogenesis (proposed).

Back to technical sheets
Class
Synthetic fragment related to thymosin β4
Also known as
Research use only; not approved for human use

Mechanism of action

Related to thymosin β4, a protein that regulates actin and participates in cell migration. Proposed effects on angiogenesis and repair are attributed to it, mainly in preclinical studies.

Evidence

Preclinical

Preclinical. Thymosin β4 has been explored in some early trials, but TB-500 as such remains in the research domain. Not approved.

Studied uses

  • Repair and healing (preclinical models)

Safety considerations

  • Human safety not established
  • Research sources without regulatory control
  • Not approved for human use

Batch quality data

We publish these figures because they are the ones the program itself teaches you to ask for.

Presentation
Polvo liofilizado en vial sellado
5 mg Coming soon
10 mg Coming soon

Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.